The House and Senate have passed S. 204, thus clearing it for the president, a bill that would have given terminally ill patients the right to seek drugs that remain in a clinical trial phase and are not yet fully approved by the Food and Drug Administration. 

Suggested Text

Thank You:

Thank you for passing the "Right to Try" bill, giving terminally ill patients the right to seek drugs that remain in a clinical trial phase and are not yet fully approved by the Food and Drug Administration. 

Opposition:

I oppose S.204 the "Right to Try" bill, and would like to know why you voted for it?

Additional Information:

Would allow patients with life-threatening diseases or conditions who are not participating in clinical trials to seek access to experimental and investigational drugs directly from a drug manufacturer, without approval by the Food and Drug Administration. It would require that in order for the patient to be eligible, the patient must first try all approved treatment options and be unable to participate in a clinical trial. Only drugs that have completed phase 1 clinical trials, that have not been approved or licensed for any use, and that are currently under an active FDA application or are undergoing clinical trials would be eligible for use under the bill's provisions.